NCT02557074View on ClinicalTrials.gov

TREg Activation in the Treatment of the PELADE (Alopecia Areata)

PHASE3CompletedINTERVENTIONAL
Enrollment

44

Participants

Timeline

Start Date

December 15, 2015

Primary Completion Date

February 2, 2019

Study Completion Date

December 2, 2019

Conditions
Alopecia Areata
Interventions
DRUG

IL2

IL2 1.5MUI/d SC from day 1 to day 5 for the first course of treatment IL2 3MUI/d SC from day 1 to day 5 for the 3 following courses

DRUG

placebo

NaCl 9% serum SC from day 1 to day 5 for the four courses of treatment

Trial Locations (6)

13005

AP-HM - La timone - Dermatologie, Marseille

30000

CHU de Nimes - Dermatologie, Nîmes

34000

CHU Montpellier - Dermatologie, Montpellier

75000

AP-HP St Louis - Dermatologie, Paris

83000

CHI St Raphael Fréjus - Dermatologie, Fréjus

06200

CHU de Nice - dermatologie, Nice

All Listed Sponsors
lead

Centre Hospitalier Universitaire de Nice

OTHER

NCT02557074 - TREg Activation in the Treatment of the PELADE (Alopecia Areata) | Biotech Hunter | Biotech Hunter